Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News LTIMindtree teams up with Aflac Incorporated to harness AWS cloud In a defining move towards a digital evolution, global tech consultant and digital solutions firm, LTIMindtree, is collaborating… byPallavi MadhirajuAugust 18, 2023